1 |
Takeda Pharmaceutical Company Limited et al v. Aurobindo Pharma Limited et al |
1:10-cv-01339 |
S.D.N.Y. |
|
|
|
|
2 |
Takeda Pharmaceutical Company Limited et al v. Aurobindo Pharma Limited et al |
1:10-cv-01339 |
S.D.N.Y. |
|
|
|
|
3 |
Takeda Pharmaceutical Company Limited et al v. Aurobindo Pharma Limited et al |
1:10-cv-01339 |
S.D.N.Y. |
|
|
|
|
4 |
MERCK, SHARP & DOHME CORP. et al v. AUROBINDO PHARMA LTD. et al |
1:13-cv-05442 |
D.N.J. |
|
|
|
|
5 |
MERCK, SHARP & DOHME CORP. et al v. AUROBINDO PHARMA LTD. et al |
1:13-cv-05442 |
D.N.J. |
|
|
|
|
6 |
MERCK, SHARP & DOHME CORP. et al v. AUROBINDO PHARMA LTD. et al |
1:13-cv-05442 |
D.N.J. |
|
|
|
|
7 |
Alcon Pharmaceuticals Ltd et al v. Aurobindo Pharma Ltd. et al |
1:14-cv-00930 |
D.Del. |
|
|
|
|
8 |
Alcon Pharmaceuticals Ltd et al v. Aurobindo Pharma Ltd. et al |
1:14-cv-00930 |
D.Del. |
|
|
|
|
9 |
AstraZeneca AB v. Aurobindo Pharma Ltd. et al |
1:14-cv-01469 |
D.Del. |
|
|
|
|
10 |
BRISTOL-MYERS SQUIBB COMPANY v. AUROBINDO PHARMA U.S.A., INC. et al |
1:14-cv-03585 |
D.N.J. |
|
|
|
|
11 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
12 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
13 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
14 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
15 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
16 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
17 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
18 |
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al. |
1:16-cv-01299 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
19 |
AUROBINDO PHARMA USA INC. et al v. APICORE US LLC et al |
1:16-cv-03358 |
D.N.J. |
|
|
|
|
20 |
AUROBINDO PHARMA USA INC. et al v. APICORE US LLC et al |
1:16-cv-03358 |
D.N.J. |
|
|
|
|
21 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
22 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
23 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
24 |
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al |
1:16-cv-04414 |
D.N.J. |
|
|
|
|
25 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
26 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
27 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
28 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
29 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
30 |
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al |
1:17-cv-00483 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
31 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
32 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
33 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
34 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
35 |
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al |
1:18-cv-01673 |
D.Del. |
|
|
|
|
36 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
37 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
38 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
39 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. AUROBINDO PHARMA LIMITED et al |
2:10-cv-00319 |
D.N.J. |
|
|
|
|
40 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. AUROBINDO PHARMA LIMITED et al |
2:10-cv-00319 |
D.N.J. |
|
|
|
|
41 |
Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al |
2:16-cv-00491 |
E.D.Tex. |
|
|
|
|
42 |
Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al |
2:16-cv-00491 |
E.D.Tex. |
|
|
|
|
43 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
44 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
45 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
46 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
47 |
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al |
2:17-cv-11679 |
D.N.J. |
|
|
|
|
48 |
ELI LILLY AND COMPANY v. AUROBINDO PHARMA USA, INC. et al |
3:08-cv-06137 |
D.N.J. |
|
|
|
|
49 |
NOVARTIS PHARMACEUTICALS CORPORATION v. AUROBINDO PHARMA LIMITED et al |
3:10-cv-06283 |
D.N.J. |
|
|
|
|
50 |
THE MEDICINES COMPANY v. AUROBINDO PHARMA LIMITED et al |
3:14-cv-02367 |
D.N.J. |
|
|
|
|